Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo
Rodney B. Luwor(The Royal Melbourne Hospital)
Cited by 84
Related Papers
<p>Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies</p>
|OncoTargets and Therapy|2019|197
Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth
|Cancers|2018|25